Skip to main content

Table 1 Demographic and clinical characteristics of the study population before the use of anti-TB therapy

From: Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time

  DS-TB (N = 13) DR-TB (N = 7) p
Age (years) 33 (25–44) 56 (27–67) 0.057
Male, n(%) 6 (46%) 4 (57%) 0.500
Diabetes, n(%) 5 (48%) 4 (57%) 0.370
Glucose, mg/dL 106 (94–151) 132 (93–146) 0.641
Sputum culture    
 Mycobacterium tuberculosis 12 (92%) 6 (86%)
 Mycobacterium bovis 1 (8%) 1 (14%)
  1. Data is represented with median and interquartile range (IQR, 25–75). U Mann Whitney and one-sided Fisher’s exact test were used
  2. DS-TB drug-susceptible tuberculosis, DR-TB drug-resistant tuberculosis